相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL-2-dependent adaptive control of NK cell homeostasis
Georg Gasteiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
Georg Gasteiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Regulatory T Cells: Mechanisms of Differentiation and Function
Steven Z. Josefowicz et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Central Role for Interleukin-2 in Type 1 Diabetes
Maigan A. Hulme et al.
DIABETES (2012)
Immunotherapy in Type 1 Diabetes: A Shorter but More Winding Road?
Ezio Bonifacio
DIABETES (2012)
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs Yet Transiently Impairs β-cell Function
S. Alice Long et al.
DIABETES (2012)
Cutting Edge: In the Absence of TGF-β Signaling in T Cells, Fewer CD103+ Regulatory T Cells Develop, but Exuberant IFN-γ Production Renders Mice More Susceptible to Helminth Infection
Lisa A. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2012)
Cutting Edge: A Novel Mechanism Bridging Innate and Adaptive Immunity: IL-12 Induction of CD25 To Form High-Affinity IL-2 Receptors on NK Cells
Seung-Hwan Lee et al.
JOURNAL OF IMMUNOLOGY (2012)
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'
Aron M. Levin et al.
NATURE (2012)
Anti-CD25 Immunotherapy: Regulating the Regulators
John W. Rose
SCIENCE TRANSLATIONAL MEDICINE (2012)
Application of IL-2 therapy to target T regulatory cell function
Ethan M. Shevach
TRENDS IN IMMUNOLOGY (2012)
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
Yenkel Grinberg-Bleyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor α subunit CD25
Sven Letourneau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Genomic definition of multiple ex vivo regulatory T cell subphenotypes
Markus Feuerer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
How Punctual Ablation of Regulatory T Cells Unleashes an Autoimmune Lesion within the Pancreatic Islets
Markus Feuerer et al.
IMMUNITY (2009)
Cytokine-induced memory-like natural killer cells
Megan A. Cooper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding
E. Ramos-Lopez et al.
TISSUE ANTIGENS (2009)
Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells
Michal Marzec et al.
CANCER RESEARCH (2008)
Regulating Treg Cells at Sites of Inflammation
Christopher A. Lazarski et al.
IMMUNITY (2008)
Response: Regulating Treg Cells at Sites of Inflammation
Qizhi Tang et al.
IMMUNITY (2008)
Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction
Qizhi Tang et al.
IMMUNITY (2008)
Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target
Dorothy K. Sojka et al.
IMMUNOLOGY (2008)
Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation
Gui-Hua Jin et al.
INTERNATIONAL IMMUNOLOGY (2008)
T Regulatory Cells in Autoimmune Diabetes: Past Challenges, Future Prospects
Jeffrey A. Bluestone et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
IL-2/anti-IL-2 antibody complex enhances vaccine-mediated antigen-specific CD8+ T cell responses and increases the ratio of effector/memory CD8+ T cells to regulatory T cells
Sven Mostboeck et al.
JOURNAL OF IMMUNOLOGY (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation -mediated apoptosis of effector CD4+ T cells
Pushpa Pandiyan et al.
NATURE IMMUNOLOGY (2007)
Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways
Karen Dybkaer et al.
BMC GENOMICS (2007)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Jeong M. Kim et al.
NATURE IMMUNOLOGY (2007)
Recovery from diabetes in mice by beta cell regeneration
Tomer Nir et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Altered natural killer cells in type 1 diabetic patients
Melanie Rodacki et al.
DIABETES (2007)
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression
Francois Ghiringhelli et al.
IMMUNOLOGICAL REVIEWS (2006)
STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors
Gregory Verdeil et al.
JOURNAL OF IMMUNOLOGY (2006)
Selective stimulation of T cell subsets with antibody-cytokine immune complexes
O Boyman et al.
SCIENCE (2006)
CD4+-CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer
MJ Smyth et al.
JOURNAL OF IMMUNOLOGY (2006)
CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A comprehensive review of interventions in the NOD mouse and implications for translation
LKM Shoda et al.
IMMUNITY (2005)
Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ
Y Laouar et al.
NATURE IMMUNOLOGY (2005)
Regulation of CD4+CD25+ regulatory T cell activity:: it takes (IL-)two to tango
A Scheffold et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
CD25+CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production
T Barthlott et al.
INTERNATIONAL IMMUNOLOGY (2005)
A contribution of mouse dendritic cell-derived IL-2 for NK cell activation
F Granucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
JC Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
M Uhl et al.
CANCER RESEARCH (2004)
RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo
MA Friese et al.
CANCER RESEARCH (2004)
KIR in type 1 diabetes: Disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects
AR van der Slik et al.
DIABETES (2003)
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2:: a potential new link between adaptive and innate immunity
TA Fehniger et al.
BLOOD (2003)
Three loci on mouse chromosome 6 influence onset and final incidence of type 1 diabetes in NOD.C3H congenic strains
UC Rogner et al.
GENOMICS (2001)
分享论文
